(Q73634952)

English

Strategies to antagonise the cyclosporine A-induced proliferation of human pulmonary artery smooth muscle cells: anti-endothelin-1 antibodies, verapamil, and octreotide

scientific article published on 01 June 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751556%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Strategies to antagonise the cyclosporine A-induced proliferation of human pulmonary artery smooth muscle cells: anti-endothelin-1 antibodies, verapamil, and octreotide (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751556%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J Medina

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751556%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Wolf

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751556%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

0 references

publication date

1 June 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751556%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Biochemical Pharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751556%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

59

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751556%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751556%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1459-1466

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751556%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Cyclosporin A in asthma therapy: a pharmacological rationale

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Newer therapeutic agents for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Trial of cyclosporin in corticosteroid-dependent chronic severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Effects of cyclosporin A and glucocorticosteroids on antigen-induced hypersensitivity to histamine in a guinea pig model of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Effect of inhaled cyclosporin on the rat airway: histologic and bronchoalveolar lavage assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Dose-related reversal of acute lung rejection by aerosolized cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Aerosolized cyclosporine in lung recipients with refractory chronic rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Coronary artery ultrastructural changes in cardiac transplant atherosclerosis in the rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Effect of cyclosporin A on rat smooth-muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Cyclosporine A stimulates proliferation of vascular smooth muscle cells and enhances monocyte adhesion to vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Vasculopathy of small muscular arteries in pediatric patients after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Cytokine profile of human bronchoalveolar macrophages and bronchial epithelial cells in response to inhalation particles of the cyclosporine derivative IMM 125.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Cyclosporine A Inhibits Induction of DNA Synthesis by PDGF and Other Peptide Mitogens in Cultured Rat Aortic Smooth Muscle Cells and Dermal Fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Growth factor activity of endothelin on vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Gene expression of the renal endothelin system in renal transplant recipients on cyclosporine A based immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

In vitro models to study mechanisms involved in cyclosporine A-mediated glomerular contraction

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Putative mediator role of endothelin-1 in asthma and other lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Bosentan ameliorates cyclosporin A-induced hypertension in rats and primates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Cyclosporine A induces endothelin-1 release from cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Preventive effects of diltiazem on cyclosporin A-induced vascular smooth muscle dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Mechanisms of the endothelial toxicity of cyclosporin A. Role of nitric oxide, cGMP, and Ca2+

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Endothelin. Pathways of transmembrane signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Non-endocrine applications of somatostatin and octreotide acetate: facts and flights of fancy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Inhibition of myointimal proliferation by octreotide in canine vein interposition grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Sandostatin inhibits development of medial proliferation of pulmonary arteries in a rat model of pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Regulation of differentiation of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900262-8

7 January 2021

Identifiers

10.1016/S0006-2952(00)00262-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751556%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751556%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73634952&oldid=1722824631"